Prognostic factors affecting recurrence and survival in patients with locally advanced rectal cancer

Journal of B.U.ON.

Volumn 17, Issue 2, 2012, Pages 291-298

  Koca, Dogan ^a   Binicier, C ^a   Oztop, I ^a   Yavuzsen, T ^a   Ellidokuz, H ^a   Yilmaz, U ^a  

^a DOKUZ EYLUL UNIVERSITY   (Turkey)

Author keywords

Locally advanced; Prognosis; Rectal cancer; Recurrence; Survival

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; FLUOROURACIL; FOLINIC ACID; OXALIPLATIN;

ADJUVANT CHEMORADIOTHERAPY; ADULT; AGED; ANTIGEN DETECTION; ARTICLE; CANCER INVASION; CANCER MORTALITY; CANCER PATIENT; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER STAGING; CANCER SURGERY; DISEASE FREE SURVIVAL; DISTANT METASTASIS; FEMALE; FOLLOW UP; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; OVERALL SURVIVAL; RECTUM CANCER; TUMOR DIFFERENTIATION;

ADENOCARCINOMA; ADENOCARCINOMA, MUCINOUS; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CARCINOEMBRYONIC ANTIGEN; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOENZYME TECHNIQUES; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROGNOSIS; RECTAL NEOPLASMS; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL; YOUNG ADULT;

EID: 84863608175     PISSN: 11070625     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Jemal A, Siegel R, Ward E et al. Cancer Statistics, 2008. CA Cancer J Clin 2008; 58: 71-96. (Pubitemid 351521864)
2. Steven KL, Leonardo BS, Joel ET. Colon Cancer. In: DeVita V, Hellman S, and Rosenberg SA (Eds): Cancer: Principles & Practice of Oncology (8th Edn). Philadelphia, Lippincott Williams & Wilkins, 2008, pp 1232-1285.
3. Benjamin RT. Gastrointestinal Cancer: Colorectal and Anal. In: Govindan R (Ed): The Washington Manual of Oncology (2nd Edn). Philadelphia, Lippincott Williams & Wilkins, 2008, pp 190-196.
4. O'Neil BH, Goldberg RM. Innovations in Chemotherapy For Metastatic Colorectal Cancer: An Update Of Recent Clinical Trials. Oncologist 2008; 13: 1074-1083.
5. Mendenhall WM, Zlotecki RA, Snead FE et al. Radiotherapy in the treatment of resectable rectal adenocarcinoma. Am J Clin Oncol 2009; 32: 629-638.
6. Steven KL, Joel ET, Leonardo BS. Rectal Cancer. In: DeVita VT, Lawrence TS, Rosenberg SA (Eds): DeVita V, Hellman S, and Rosenberg SA: Cancer: Principles & Practice of Oncology (8th Edn). Philadelphia, Lippincott Williams & Wilkins, 2008, pp 1285-1301.
7. Cui J, Wang JP, Huang YH, Xiang J. Evaluation of risk factors associated with local recurrence after radical resection of rectal carcinoma. Zhonghua Wei Chang Wai Ke Za Zhi 2008; 11: 322-325.
8. Ianosi G, Mercut D, Neagoe D et al. Histopathological factors as predictors for survival in colon and rectal cancers. Rom J Morphol Embryol 2008; 49: 365-369.
9. Das P, Skibber JM, Rodriguez-Bigas MA et al. Clinical and pathologic predictors of locoregional recurrence, distant metastasis, and overall survival in patients treated with chemoradiation and mesorectal excision for rectal cancer. Am J Clin Oncol 2006; 29: 219-224. (Pubitemid 44270928)
10. Dardanov D, Betova T, Deliyski T. Investigation of circumferential resection margin in rectal cancer surgery. J BUON 2007; 12: 369-376. (Pubitemid 47559304)
11. Chari RS, Tyler DS, Anscher MS et al. Preoperative radiation and chemotherapy in the treatment of adenocarcinoma of the rectum. Ann Surg 1995; 221: 778-787.
12. Sauer R, Becker H, Hohenberger W et al. Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med 2004; 21; 351: 1731-1740.
13. Roh MS, Colangelo LH, O'Connell MJ et al. Preoperative multimodality therapy improves disease-free survival in patients with carcinoma of the rectum: NSABP R-03. J Clin Oncol 2009; 27: 5124-5130.
14. Bachet JB, Rougier P, de Gramont A, Andre T. Rectal cancer and adjuvant chemotherapy: which conclusions? Bull Cancer 2010; 97: 107-122.
15. Tentes AA, Korakianitis OS, Veliovic D, Sgouridou E, Karagiozoglou C, Moustakas K. The impact of total mesorectal excision in middle and low rectal carcinomas. J BUON 2010; 15: 56-60.
16. American Joint Committee on Cancer. Colon and Rectum. Philadelphia: Lippincott-Raven Publishers, 2002.
17. Bannura G, Cumsille MA, Contreras J, Barrera A, Melo C, Soto D. Carcinoembryonic antigen (CEA) as an independent prognostic factor in colorectal carcinoma. Rev Med Chil 2004; 132: 691-700.
18. Shen SS, Haupt BX, Ro JY, Zhu J, Bailey HR, Schwartz MR. Number of lymph nodes examined and associated clinicopathologic factors in colorectal carcinoma. Arch Pathol Lab Med 2009; 133: 781-786.
19. Goldstein MJ, Mitchell EP. Carcinoembryonic antigen in the staging and follow-up of patients with colorectal cancer. Cancer Invest 2005; 23: 338-351. (Pubitemid 41656973)
20. Liebig C, Ayala G, Wilks JA, Berger DH, Albo D. Perineural invasion in cancer: a review of the literature. Cancer 2009; 115: 3379-3391.
21. Dresen RC, Peters EE, Rutten HJ et al. Local recurrence in rectal cancer can be predicted by histopathological factors. Eur J Surg Oncol 2009; 35: 1071-1077.
22. Jung B, Pahlman L, Johansson R, Nilsson E. Rectal cancer treatment and outcome in the elderly: an audit based on the Swedish Rectal Cancer Registry 1995-2004. BMC Cancer 2009; 26; 9:68.
23. Huh JW, Kim HR. Postoperative chemotherapy after neoadjuvant chemoradiation and surgery for rectal cancer: is it essential for patients with ypT0-2N0? J Surg Oncol 2009; 100: 387-391.
24. Slampa R, Kocakova I, Sefr R et al. Neoadjuvant treatment for locally advanced rectal adenocarcinoma with concomitant radiotherapy and oral capecitabine. J BUON 2004; 9: 33-40. (Pubitemid 38660104)
25. Rodel C, Martus P, Papadopoulos T et al. Prognostic significance of tumor regression after preoperative chemoradiotherapy for rectal cancer. J Clin Oncol 2005; 23: 8688-8696. (Pubitemid 46211512)
26. Yoon SM, Kim DY, Kim TH et al. Clinical parameters predicting pathologic tumor response after preoperative chemoradiotherapy for rectal cancer. Int J Radiat Oncol Biol Phys 2007; 15; 69: 1167-1172. (Pubitemid 47625840)
27. Ciccocioppo A, Stephens JH, Hewett PJ, Rieger NA. Complete pathologic response after preoperative rectal cancer chemoradiotherapy. ANZ J Surg 2009; 79: 481-484.